Abstract
Objective: To determine the effects of antiretroviral therapy on thymic output independent of HIV infection. Methods: Thymic output was evaluated by quantifying signal joint T-cell receptor (TCR) recombination excision circles in peripheral blood lymphocytes from HIV-negative patients undergoing prophylactic antiretroviral therapy. Additionally, effects of the HIV protease inhibitor nelfinavir were assessed in vivo on TCR-induced death of murine double-positive thymocytes. Results: Five out of seven HIV-negative patients undergoing prophylactic antiretroviral therapy exhibited a dramatic increase (1-3 log 10) in recent thymic emigrants containing signal joint TCR recombination excision circles while their peripheral T cell compartments remained relatively unaffected. None of the patients developed subsequent HIV infections. Interestingly, nelfinavir did not have significant effects on TCR-induced apoptosis of murine thymocytes in vivo. Conclusion: Antiretroviral therapy augments thymic output independent of HIV. Furthermore, nelfinavir does not dramatically affect TCR-induced thymocyte death in mice, thus central tolerance remains intact.
Original language | English (US) |
---|---|
Pages (from-to) | 1467-1472 |
Number of pages | 6 |
Journal | AIDS |
Volume | 19 |
Issue number | 14 |
DOIs | |
State | Published - Sep 23 2005 |
Keywords
- Antiretroviral therapy
- Apoptosis
- Protease inhibitors
- Recent thymic emigrants
- Thymocytes
- sjTRECS
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Infectious Diseases